MedTrace Logo

Changes in Gene Expression and Prognosis of Blood Immune Cells After Cardiopulmonary Bypass Surgery

NCT05871203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2023-05-23

No results posted yet for this study

Summary

The goal of this observational study is to learn about the changes in gene expression in blood immune cells in after cardiac surgery with cardiopulmonary bypass.The main question it aims to answer is: What specific gene expression changes predict kidney damage after cardiac surgery with cardiopulmonary bypass. Participants received conventional treatment.

Conditions

Interventions

OTHER

Gene sequencing

Participants were taken blood samples for gene sequencing at three time periods: before, after, and 24 hours after the end of the surgery

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-17
Primary Completion
2023-06-30
Completion
2023-07-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871203 on ClinicalTrials.gov